Table 1.
Drug name | Target | Compound | Stage of Development |
---|---|---|---|
GLS4 | Interfere with capsid formation/stability | Heteroaryldihydropyrimidine (HAPs) | Phase II |
Bay 41-4109 | Viral nucleocapsid inhibitor | HAPs | Phase I |
AT-130 | Inhibition of HBV capsid assembly | Phenylpropenamide derivatives | Preclinical and early clinical phase |
NVR-3-778 (NVR1221) | Inhibition of HBV capsid assembly | Small molecule | Phase Ib |